Mercury Laboratories Limited Share Price

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.As of 15 Jun 2026, Mercury Laboratories Limited share price is ₹775.00. The stock opened at ₹758.85, compared to its previous close of ₹758.85. During today's trading session, Mercury Laboratories Limited share price moved in the range of ₹758.85 to ₹775.00, with an average price of ₹766.92 for the day. Looking at its last 52-week, the stock has touched a low of ₹758.85 and a high of ₹775.00.

The market capitalization of Mercury Laboratories Limited is ₹93 Crs, with a P/E ratio of 19.2 and a dividend yield of 0.45%.